Literature DB >> 11440519

Sacroiliac dysfunction in dancers with low back pain.

L. E. DeMann1.   

Abstract

SUMMARY. Low back pain is a common occurrence in dancers. Studies have shown its prevalence to be around 12% of all dance type of injuries. It is commonly thought by health professionals who specialize in dance medicine that sacroiliac (SI) dysfunction is one of the more common causes of low back pain in dancers. The aetiology of SI dysfunction in dancers is related to both the biomechanics of the SI joint and the physiological demands placed on the SI joint from the dynamics of dance. Injury to the SI joint can be due to a combination of a single traumatic incident, from overuse factors involving repetitive microtrauma or from emotional stress. Clinical manifestations could be pain in the back, buttock, hip and leg, and limitation of movement specific to dance. Diagnosis is based upon the deviation from normal of both the static and kinetic functions of the low back and pelvis in its relationship to the biomechanics of dance. Treatment is aimed at relieving pain, restoring the function of the SI joint and returning the dancer to full function. Copyright 1997 Harcourt Publishers Ltd.

Entities:  

Year:  1997        PMID: 11440519     DOI: 10.1054/math.1997.0280

Source DB:  PubMed          Journal:  Man Ther        ISSN: 1356-689X


  3 in total

1.  Diagnosis and management of "an apparent mechanical" femoral mononeuropathy: a case study.

Authors:  Ariane Desmarais; Martin Descarreaux
Journal:  J Can Chiropr Assoc       Date:  2007-12

2.  Kinematic analysis of modern dance movement "stag jump" within the context of impact loads, injury to the locomotor system and its prevention.

Authors:  Joanna Gorwa; Lechosław B Dworak; Robert Michnik; Jacek Jurkojć
Journal:  Med Sci Monit       Date:  2014-06-27

3.  On the track of the ideal turnout: Electromyographic and kinematic analysis of the five classical ballet positions.

Authors:  Joanna Gorwa; Jarosław Kabaciński; Michał Murawa; Anna Fryzowicz
Journal:  PLoS One       Date:  2020-03-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.